122 related articles for article (PubMed ID: 17434826)
21. In vitro activity of fluconazole and voriconazole against clinical isolates of Candida spp. by E-test method.
Madhavan P; Jamal F; Chong PP; Ng KP
Trop Biomed; 2010 Aug; 27(2):200-7. PubMed ID: 20962716
[TBL] [Abstract][Full Text] [Related]
22. Are disk diffusion and Etest methods reliable for detecting Candida glabrata and other species' susceptibility to fluconazole and voriconazole?
Kiraz N; Oz Y; Dag I
J Chemother; 2010 Aug; 22(4):280-2. PubMed ID: 20685635
[No Abstract] [Full Text] [Related]
23. In vitro activity of fluconazole, voriconazole and caspofungin against clinical yeast isolates.
Maida CM; Milici ME; Oliveri S
J Chemother; 2007 Jun; 19(3):277-82. PubMed ID: 17594922
[TBL] [Abstract][Full Text] [Related]
24. Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata.
Posteraro B; Martucci R; La Sorda M; Fiori B; Sanglard D; De Carolis E; Florio AR; Fadda G; Sanguinetti M
J Clin Microbiol; 2009 Jun; 47(6):1927-30. PubMed ID: 19403774
[TBL] [Abstract][Full Text] [Related]
25. Broth medium for microdilution susceptibility tests of fluconazole and voriconazole.
Barry A; Brown S; Traczewski M
Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):407-10. PubMed ID: 12072930
[No Abstract] [Full Text] [Related]
26. Susceptibility to voriconazole, fluconazole, and ketoconazole of yeast isolated from patients with hematological malignancies.
Nawrot U; Nowicka J; Wlodarczyk K
J Chemother; 2008 Dec; 20(6):758-60. PubMed ID: 19129078
[No Abstract] [Full Text] [Related]
27. Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation.
Kronvall G; Karlsson I
J Clin Microbiol; 2001 Apr; 39(4):1422-8. PubMed ID: 11283066
[TBL] [Abstract][Full Text] [Related]
28. Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
Quindós G; Sánchez-Vargas LO; Villar-Vidal M; Eraso E; Alkorta M; Hernández-Almaraz JL
Int J Antimicrob Agents; 2008 Mar; 31(3):266-71. PubMed ID: 18054468
[TBL] [Abstract][Full Text] [Related]
29. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
[TBL] [Abstract][Full Text] [Related]
30. Use of the BIOMIC Video System to evaluate the susceptibility of clinical yeast isolates to fluconazole and voriconazole by a disk diffusion method.
Dóczi I; Mestyán G; Puskás E; Nikolova R; Barcs I; Nagy E
Acta Microbiol Immunol Hung; 2006 Jun; 53(2):135-44. PubMed ID: 16956125
[TBL] [Abstract][Full Text] [Related]
31. In vitro activities of voriconazole and five licensed antifungal agents against Candida dubliniensis: comparison of CLSI M27-A2, Sensititre YeastOne, disk diffusion, and Etest methods.
Salgado-Parreño FJ; Alcoba-Flórez J; Arias A; Moragues MD; Quindós G; Pontón J; Arévalo MP
Microb Drug Resist; 2006; 12(4):246-51. PubMed ID: 17227209
[TBL] [Abstract][Full Text] [Related]
32. Comparison of two antifungal susceptibility testing of Candida sp. isolates using agar diffusion method: Neo-sensitabs® tablets and Bio-rad® disks.
Uwingabiye J; Iken M; Zohoun AG; Boumhil L; Lemkhente Z; Naoui H; Bouchrik M; Lmimouni B
J Mycol Med; 2016 Mar; 26(1):61-5. PubMed ID: 26471055
[TBL] [Abstract][Full Text] [Related]
33. Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study.
Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M; Fothergill A; Pfaller MA; Rinaldi M; Rodriguez-Tudela JL; Verweij PE
J Clin Microbiol; 2005 Sep; 43(9):4535-40. PubMed ID: 16145103
[TBL] [Abstract][Full Text] [Related]
34. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.
Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M; Pfaller MA; Rinaldi M; Rodriguez-Tudela JL; Verweij PE
J Clin Microbiol; 2005 Aug; 43(8):3884-9. PubMed ID: 16081926
[TBL] [Abstract][Full Text] [Related]
35. [Species distribution and antifungal susceptibilities of yeast clinical isolates from three hospitals in Korea, 2001 to 2007].
Lee MK; Yong D; Kim M; Kim MN; Lee K
Korean J Lab Med; 2010 Aug; 30(4):364-72. PubMed ID: 20805708
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven tertiary hospitals in São Paulo state, Brazil.
Purisco SU; Martins MA; Szeszs MW; Castro e Silva DM; Pukinskas SR; Bonfietti LX; Baez AA; Melhem MS
FEMS Yeast Res; 2012 Dec; 12(8):890-6. PubMed ID: 22883021
[TBL] [Abstract][Full Text] [Related]
37. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
38. Anticryptococcal activity of voriconazole against Cryptococcus neoformans var. gatti vs var. neoformans: comparison with fluconazole and effect of human serum.
Brummer E; Kamei K; Miyaji M
Mycopathologia; 1998; 142(1):3-7. PubMed ID: 9850592
[TBL] [Abstract][Full Text] [Related]
39. Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.
Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Barton R; Bijie H; Bille J; Chang SC; da Luz Martins M; Duse A; Dzierzanowska D; Ellis D; Finquelievich J; Gould I; Gur D; Hoosen A; Lee K; Mallatova N; Mallie M; Peng NG; Petrikos G; Santiago A; Trupl J; VanDen Abeele AM; Wadula J; Zaidi M;
Diagn Microbiol Infect Dis; 2010 Jun; 67(2):162-71. PubMed ID: 20338711
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole.
Pfaller MA; Diekema DJ; Boyken L; Messer SA; Tendolkar S; Hollis RJ
J Clin Microbiol; 2003 May; 41(5):1875-80. PubMed ID: 12734220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
